Zinc Toxicosis

Zinc toxicosis is a potentially life-threatening condition in veterinary medicine resulting from the excessive ingestion or absorption of zinc, leading to systemic toxicity. Zinc is an essential trace element required for numerous enzymatic functions, DNA synthesis, immune response, and cellular metabolism. However, when present in excessive amounts, zinc becomes highly toxic, primarily causing hemolytic anemia, gastrointestinal irritation, and multi-organ dysfunction. The condition is most commonly reported in dogs, with cats being less frequently affected due to their more selective dietary habits. Zinc toxicosis can manifest acutely or chronically, depending on the source and amount of zinc ingested. Common sources include galvanized metal objects (e.g., nuts, bolts, wire, cages), pennies minted after 1982 (which contain 97.5% zinc), zinc oxide ointments, dietary supplements, and certain fertilizers. The clinical presentation ranges from mild gastrointestinal signs to severe hemolytic crisis, acute kidney injury, hepatic necrosis, and pancreatitis. Prompt recognition and aggressive decontamination and chelation therapy are essential for a favorable outcome. This entry provides a comprehensive overview of zinc toxicosis, including its etiology, pathophysiology, clinical signs, diagnostic approach, treatment protocols, and prognosis, based on current veterinary literature and expert consensus.

Zinc toxicosis is caused by the ingestion of exogenous sources of zinc, leading to excessive absorption and systemic toxicity. The most common sources in veterinary practice include: 1) Galvanized metal objects: These are coated with a layer of zinc to prevent corrosion. Common items include nuts, bolts, screws, wire, fencing, cages, and hardware cloth. Dogs, particularly those with pica or destructive chewing behaviors, are at high risk. 2) US pennies minted after 1982: These pennies are composed of 97.5% zinc with a thin copper plating. Ingestion of even a single penny can cause significant toxicity, especially if chewed, as gastric acid accelerates zinc release. 3) Zinc oxide ointments: Topical preparations such as diaper rash creams, sunscreens, and medicated ointments contain zinc oxide. Ingestion of these products can lead to toxicity, especially in small animals. 4) Dietary supplements: Zinc supplements intended for humans or animals, including multivitamins and mineral supplements, can be toxic if ingested in large quantities. 5) Other sources: Zinc-containing fertilizers, paints, pigments, and certain automotive parts (e.g., wheel weights) may also be ingested. The toxic dose of zinc varies among species and individual animals. In dogs, ingestion of more than 1 gram of metallic zinc can cause clinical signs, but even smaller amounts can be toxic if the object is chewed, increasing surface area and dissolution. The lethal dose is estimated to be 100-500 mg/kg of elemental zinc, but severe toxicity can occur with lower doses. Zinc is absorbed in the stomach and proximal small intestine, and its absorption is influenced by dietary factors such as phytates and calcium. Once absorbed, zinc binds to metallothionein in enterocytes and hepatocytes, and is distributed to tissues, with high concentrations in the liver, kidney, pancreas, and prostate. Toxicity occurs when the binding capacity of metallothionein is exceeded, leading to free zinc ions that disrupt cellular processes.

Zinc toxicosis is most commonly reported in dogs, with a higher incidence in young dogs and certain breeds known for oral exploration and pica, such as Labrador Retrievers, Golden Retrievers, and other retrievers. However, any dog can be affected if exposed to zinc-containing objects. Cats are less commonly affected due to their more discerning eating habits, but cases have been reported, particularly with ingestion of zinc oxide ointments or small metallic objects. There is no sex predilection. The condition is often sporadic and related to environmental access to zinc sources. Geographically, zinc toxicosis is more frequently diagnosed in regions where galvanized metal products are common, such as rural or agricultural areas, and in households with older US pennies. Seasonality is not significant, but cases may increase during holidays or home renovation projects when access to zinc-containing materials is higher. The incidence of zinc toxicosis is relatively low compared to other toxicities, but it is a significant cause of hemolytic anemia in dogs. A retrospective study found that zinc toxicosis accounted for approximately 0.2% of all toxicosis cases in dogs, but the true incidence may be underestimated due to misdiagnosis. Early recognition and treatment are critical, as mortality rates can be high if chelation therapy is delayed.

The pathophysiology of zinc toxicosis is complex and involves multiple organ systems. The primary mechanism of toxicity is the disruption of cellular homeostasis by free zinc ions. Zinc is an essential cofactor for over 300 enzymes, but excessive free zinc interferes with copper absorption and metabolism, leading to secondary copper deficiency. Copper is crucial for the function of cytochrome c oxidase, superoxide dismutase, and other enzymes involved in antioxidant defense and cellular respiration. Copper deficiency results in oxidative stress, particularly in red blood cells, leading to hemolysis. Additionally, zinc directly damages red blood cell membranes by inhibiting the sodium-potassium ATPase pump and increasing membrane fragility, causing intravascular and extravascular hemolysis. Hemolysis leads to anemia, hemoglobinemia, hemoglobinuria, and the release of free hemoglobin, which can cause acute kidney injury due to tubular obstruction and direct nephrotoxicity. Zinc also induces the production of metallothionein, which binds zinc and copper, further exacerbating copper deficiency. In the gastrointestinal tract, zinc causes direct mucosal irritation, leading to vomiting, diarrhea, and abdominal pain. Systemically, zinc can cause pancreatitis, hepatic necrosis, and myocardial damage. The exact mechanisms of organ damage involve oxidative stress, mitochondrial dysfunction, and apoptosis. Zinc also affects the immune system, causing immunosuppression and increased susceptibility to infections. The severity of clinical signs correlates with the amount of zinc absorbed and the duration of exposure. Acute ingestion of a large amount of zinc can cause rapid onset of hemolysis within 24-48 hours, while chronic ingestion of smaller amounts may lead to more insidious signs such as weight loss, lethargy, and chronic anemia.

Several factors predispose animals to zinc toxicosis: 1) Age: Young animals, especially puppies, are more likely to ingest non-food items due to their exploratory behavior and teething. 2) Breed: Certain breeds, such as Labrador Retrievers, are known for their tendency to chew and ingest objects. 3) Behavioral factors: Pica, a condition characterized by the ingestion of non-nutritive substances, is a significant risk factor. 4) Environmental access: Animals with access to galvanized metal objects, pennies, or zinc-containing ointments are at higher risk. 5) Concurrent dietary deficiencies: Diets low in copper or high in phytates may increase zinc absorption and toxicity. 6) Gastrointestinal conditions: Conditions that increase gastric acidity, such as fasting, may enhance zinc dissolution and absorption. 7) Lack of supervision: Unsupervised animals are more likely to ingest foreign objects. 8) Owner awareness: Lack of awareness about the dangers of zinc-containing items can lead to accidental exposure. 9) Multiple animal households: The presence of multiple pets may increase the likelihood of ingestion due to competition or play. 10) Seasonal factors: During holidays or home improvement projects, the availability of zinc-containing items may increase.

Clinical signs of zinc toxicosis can vary depending on the dose, duration of exposure, and individual susceptibility. The onset of signs is typically within 24-48 hours after ingestion, but can be delayed in cases of chronic exposure. The most common early signs are gastrointestinal: vomiting (often with blood), diarrhea, anorexia, and abdominal pain. These signs are followed by systemic signs due to hemolysis, which may include: 1) Lethargy and weakness: Due to anemia and systemic illness. 2) Pale mucous membranes: Resulting from anemia. 3) Icterus (jaundice): Due to hemolysis and hepatic involvement. 4) Hemoglobinuria: Dark red or brown urine due to free hemoglobin. 5) Tachycardia and tachypnea: Compensatory responses to anemia. 6) Fever: May be present due to inflammation or secondary infection. 7) In severe cases, signs of acute kidney injury: Oliguria or anuria, azotemia, and electrolyte imbalances. 8) Neurological signs: In rare cases, seizures, ataxia, or depression may occur due to hepatic encephalopathy or direct CNS toxicity. 9) Pancreatitis: May manifest as severe abdominal pain, vomiting, and elevated pancreatic enzymes. 10) Coagulopathy: Disseminated intravascular coagulation (DIC) can occur in severe cases. Chronic zinc toxicosis may present with more subtle signs such as weight loss, poor coat condition, and chronic intermittent gastrointestinal signs. Physical examination may reveal evidence of a foreign body in the gastrointestinal tract, such as a palpable mass or radiographic findings.

The differential diagnoses for zinc toxicosis include: 1) Immune-mediated hemolytic anemia (IMHA): This condition also presents with hemolytic anemia, but is typically associated with autoagglutination, positive Coombs test, and lack of exposure to zinc. 2) Other heavy metal toxicities: Lead poisoning can cause gastrointestinal and neurological signs, but hemolysis is less common. Copper toxicity, particularly in Bedlington Terriers, can cause hemolytic crisis and hepatic necrosis. 3) Onion or garlic toxicity: Ingestion of these foods can cause oxidative damage to red blood cells, leading to Heinz body formation and hemolysis. 4) Acetaminophen toxicity: In cats, acetaminophen causes methemoglobinemia and hemolysis. 5) Snake envenomation: Some snake venoms can cause hemolysis and coagulopathy. 6) Babesiosis: A tick-borne parasitic infection that causes hemolytic anemia. 7) Microangiopathic hemolytic anemia: Conditions such as DIC or vasculitis can cause red blood cell fragmentation. 8) Hypophosphatemia: Severe hypophosphatemia can cause hemolysis. 9) Inherited red blood cell defects: Such as pyruvate kinase deficiency in Basenjis or phosphofructokinase deficiency in English Springer Spaniels. 10) Hepatic disease: Severe liver disease can cause icterus and coagulopathy, but hemolysis is not a primary feature. To differentiate these conditions, a thorough history of potential zinc exposure, complete blood count, serum biochemistry, urinalysis, and specific tests such as blood zinc levels, Coombs test, and blood smear evaluation for Heinz bodies or spherocytes are essential.

The diagnostic approach to suspected zinc toxicosis should be systematic and prompt. Step 1: Obtain a thorough history, including any potential exposure to zinc-containing objects (e.g., pennies, galvanized metal, zinc oxide ointment). Step 2: Perform a complete physical examination, paying attention to mucous membrane color, heart rate, respiratory rate, and abdominal palpation for foreign bodies. Step 3: Baseline laboratory tests: Complete blood count (CBC) to assess for anemia, leukocytosis, and red blood cell morphology (spherocytes, Heinz bodies). Serum biochemistry profile to evaluate liver enzymes (ALT, AST), renal parameters (BUN, creatinine), pancreatic enzymes (lipase, amylase), and electrolytes. Urinalysis to detect hemoglobinuria, hematuria, and casts. Step 4: If zinc toxicosis is suspected, obtain a blood sample for serum zinc concentration. Normal serum zinc levels in dogs and cats are approximately 0.7-2.0 ppm (mg/L) or 10-30 μmol/L. Levels above 2 ppm (30 μmol/L) are considered toxic, but clinical signs may occur at lower levels. Step 5: Abdominal radiographs to identify radiopaque foreign bodies (e.g., pennies, metal objects) in the gastrointestinal tract. Step 6: If the diagnosis is uncertain, consider additional tests such as blood gas analysis, coagulation profile, and blood smear for Heinz bodies. Step 7: In cases of chronic exposure, liver biopsy may be indicated to assess hepatic copper and zinc levels. Step 8: Monitor response to chelation therapy; a decrease in serum zinc levels and improvement in clinical signs support the diagnosis. Step 9: Rule out other causes of hemolytic anemia through specific tests such as Coombs test, infectious disease testing (e.g., Babesia), and red blood cell enzyme assays if indicated.

Laboratory findings in zinc toxicosis are characteristic and include: 1) Hematology: Regenerative anemia (increased reticulocyte count) with spherocytosis and Heinz bodies on blood smear. Leukocytosis with a left shift may be present due to inflammation. Thrombocytopenia may occur in cases of DIC. 2) Serum biochemistry: Elevated liver enzymes (ALT, AST, ALP) due to hepatic necrosis. Hyperbilirubinemia (elevated total and direct bilirubin) due to hemolysis and hepatic dysfunction. Azotemia (elevated BUN and creatinine) due to acute kidney injury. Hyperphosphatemia and hyperkalemia may occur with renal failure. Elevated amylase and lipase may indicate pancreatitis. Hypocalcemia and hypomagnesemia have been reported. 3) Urinalysis: Hemoglobinuria (positive for blood on dipstick but no red blood cells on sediment), proteinuria, and granular casts. 4) Blood gas analysis: Metabolic acidosis may be present due to lactic acidosis from tissue hypoxia and renal dysfunction. 5) Serum zinc concentration: Elevated above 2 ppm (30 μmol/L). 6) Coagulation profile: Prolonged PT and aPTT, elevated D-dimers, and decreased fibrinogen in cases of DIC. 7) Other biomarkers: Elevated C-reactive protein (CRP) as an inflammatory marker. 8) Blood smear: Heinz bodies (denatured hemoglobin precipitates) and spherocytes are commonly seen. 9) Bone marrow evaluation: Erythroid hyperplasia in response to anemia.

Imaging plays a crucial role in the diagnosis of zinc toxicosis, primarily to identify radiopaque foreign bodies in the gastrointestinal tract. 1) Radiography: Abdominal radiographs (lateral and ventrodorsal views) are essential. Zinc-containing objects such as pennies, nuts, bolts, and wire are radiopaque and can be visualized. Pennies minted after 1982 appear as small, round, radiopaque objects. Radiographs can also reveal signs of gastrointestinal obstruction or perforation, such as free gas in the abdomen. 2) Ultrasonography: Abdominal ultrasound may be useful to assess for pancreatitis (enlarged, hypoechoic pancreas), hepatomegaly, and renal changes (increased cortical echogenicity). It can also help identify foreign bodies that are not clearly visible on radiographs. 3) Computed Tomography (CT): CT may be used in complex cases to better localize foreign bodies and assess for complications such as abscesses or perforation. 4) Endoscopy: Upper gastrointestinal endoscopy can be used to visualize and retrieve foreign bodies from the stomach or proximal duodenum. This is both diagnostic and therapeutic. 5) Echocardiography: In cases of suspected myocardial damage, echocardiography may reveal decreased contractility or arrhythmias. Imaging findings, combined with history and laboratory tests, are crucial for confirming the diagnosis and guiding treatment.

Cytology and histopathology are not typically required for the diagnosis of zinc toxicosis, but they may be performed in certain situations. 1) Fine needle aspirate (FNA) of the liver: May show hepatocellular vacuolation, necrosis, and increased copper or zinc content if special stains are used. 2) Bone marrow aspirate: May reveal erythroid hyperplasia in response to hemolytic anemia. 3) Histopathology of the liver: Findings include hepatocellular necrosis, fatty change, and cholestasis. Special stains such as rhodanine for copper or dithizone for zinc can demonstrate metal accumulation. 4) Histopathology of the kidney: Acute tubular necrosis, hemoglobin casts in tubules, and interstitial nephritis may be seen. 5) Histopathology of the pancreas: Acute pancreatitis with necrosis and inflammation. 6) Histopathology of the gastrointestinal tract: Mucosal erosion, ulceration, and hemorrhage. These findings are non-specific but can support the diagnosis when combined with clinical and laboratory evidence. In cases of chronic zinc toxicosis, liver biopsy may be performed to assess for secondary copper deficiency, which is characterized by decreased copper levels and increased zinc levels.

Treatment of zinc toxicosis involves several key components: 1) Emergency stabilization: Assess and stabilize the patient's airway, breathing, and circulation. Administer intravenous fluids (e.g., lactated Ringer's solution or 0.9% saline) at a rate of 10-20 ml/kg/h to maintain perfusion and promote diuresis. 2) Decontamination: If ingestion occurred within 2-4 hours and the animal is asymptomatic, induce vomiting with 3% hydrogen peroxide (1-2 ml/kg, max 50 ml) or apomorphine (0.03 mg/kg IV or 0.04 mg/kg IM). However, if the object is sharp or large, do not induce vomiting. Administer activated charcoal (1-2 g/kg PO) to bind zinc, but note that it may not be effective for metallic objects. 3) Foreign body removal: If a radiopaque foreign body is present in the stomach or intestines, endoscopic retrieval or surgical removal is indicated. This is the most critical step to prevent ongoing zinc absorption. 4) Chelation therapy: The primary treatment for zinc toxicosis is chelation with calcium disodium EDTA (CaNa2EDTA) or D-penicillamine. CaNa2EDTA is administered at a dose of 100 mg/kg/day IV, divided into 4 doses (q6h) or as a continuous rate infusion (CRI) for 5 days. D-penicillamine is given at a dose of 110 mg/kg/day PO, divided into 4 doses (q6h) for 1-2 weeks. Alternatively, succimer (meso-2,3-dimercaptosuccinic acid) can be used at a dose of 10 mg/kg PO q8h for 10 days. Chelation therapy should be continued until serum zinc levels return to normal and clinical signs resolve. 5) Supportive care: Blood transfusion may be necessary if anemia is severe (PCV < 20% or clinical signs of hypoxia). Administer oxygen therapy if needed. Monitor and correct electrolyte imbalances. Administer antiemetics (e.g., maropitant 1 mg/kg SC q24h) for vomiting. Gastroprotectants such as omeprazole (0.7-1.5 mg/kg PO q24h) or famotidine (0.5-1 mg/kg IV/PO q12h) may be used. 6) Management of complications: Acute kidney injury may require aggressive fluid therapy, diuretics (e.g., furosemide 1-2 mg/kg IV q8h), and possibly dialysis in severe cases. Pancreatitis requires supportive care with pain management (e.g., opioids), and withholding food initially. Hepatic failure may require hepatoprotectants such as S-adenosylmethionine (SAMe) and vitamin E. 7) Nutritional support: Once vomiting is controlled, provide a bland, easily digestible diet. 8) Monitoring: Serial monitoring of PCV, serum zinc levels, renal and liver function, and urine output is essential.

The prognosis for zinc toxicosis is generally good if treatment is initiated early and the source of zinc is removed promptly. With appropriate chelation therapy and supportive care, most animals recover within 1-2 weeks. However, the prognosis can be guarded to poor in cases of severe hemolysis, acute kidney injury, or pancreatitis. Mortality rates are reported to be around 5-10% in dogs, but may be higher if treatment is delayed. Negative prognostic indicators include: 1) Severe anemia (PCV < 15%) at presentation. 2) Acute kidney injury requiring dialysis. 3) Disseminated intravascular coagulation (DIC). 4) Hepatic failure. 5) Pancreatitis with systemic complications. 6) Delayed initiation of chelation therapy. 7) Presence of multiple or large foreign bodies. 8) Concurrent ingestion of other toxins. With aggressive treatment, even severely affected animals can recover, but long-term monitoring for chronic kidney disease or hepatic dysfunction may be necessary. Recurrence is possible if the animal has continued access to zinc-containing objects, so owner education is crucial.

Follow-up care for animals with zinc toxicosis is essential to ensure complete recovery and monitor for long-term complications. 1) Recheck examinations: Schedule recheck appointments at 1 week, 2 weeks, and 1 month after discharge. 2) Laboratory monitoring: Serial CBC, serum biochemistry, and urinalysis should be performed to monitor for resolution of anemia, renal function, and liver enzymes. Serum zinc levels should be rechecked 1-2 weeks after cessation of chelation therapy to ensure they have returned to normal. 3) Imaging: If a foreign body was removed surgically or endoscopically, follow-up radiographs may be taken to confirm complete removal. 4) Renal function: Monitor BUN, creatinine, and urine specific gravity for at least 3 months to detect chronic kidney disease. 5) Hepatic function: Monitor liver enzymes and bilirubin until they normalize. 6) Pancreatic function: If pancreatitis occurred, monitor amylase and lipase, and consider a low-fat diet long-term. 7) Owner education: Advise owners to remove all zinc-containing objects from the animal's environment and to supervise the animal to prevent future ingestion. 8) Dietary considerations: If copper deficiency is suspected, consider copper supplementation under veterinary guidance. 9) Long-term monitoring: In cases of chronic zinc toxicosis, periodic monitoring of liver function and zinc levels may be indicated. 10) Document any residual clinical signs such as polyuria, polydipsia, or chronic vomiting.

Clinical Pearls: 1) Always consider zinc toxicosis in any dog with acute hemolytic anemia and a history of pica or access to pennies or galvanized metal. 2) Radiographs are essential; pennies and many metal objects are radiopaque. 3) Serum zinc levels are diagnostic, but treatment should not be delayed while waiting for results. 4) Early removal of the foreign body is the most critical step; chelation alone is insufficient if the source remains. 5) CaNa2EDTA is the chelator of choice for severe cases; D-penicillamine is an alternative for oral therapy. 6) Blood transfusions may be life-saving in severe anemia. 7) Monitor for acute kidney injury, as hemoglobinuria can cause tubular damage. 8) Zinc toxicosis can cause pancreatitis; monitor pancreatic enzymes. 9) In cats, zinc toxicosis is rare but can occur with ingestion of zinc oxide ointment; treat similarly. 10) Prognosis is excellent with prompt treatment. Clinical Pitfalls: 1) Delaying treatment while waiting for serum zinc results can be fatal. 2) Inducing vomiting if the object is sharp or large can cause esophageal or gastric damage. 3) Administering activated charcoal may not bind metallic zinc effectively. 4) Using D-penicillamine in animals with renal impairment may be contraindicated. 5) Failing to monitor for DIC can lead to uncontrolled bleeding. 6) Overlooking concurrent copper deficiency can lead to persistent anemia. 7) Discontinuing chelation therapy too early may result in recurrence of clinical signs. 8) Not providing adequate fluid therapy can exacerbate renal injury. 9) Ignoring the need for surgical removal if endoscopic retrieval fails. 10) Failing to educate owners about preventing future exposure.

Based on Plumb's Veterinary Drug Handbook, the following drug protocols are recommended for zinc toxicosis: 1) Calcium Disodium EDTA (CaNa2EDTA): Dose: 100 mg/kg/day IV, divided into 4 doses (q6h) or as a continuous rate infusion (CRI) for 5 days. Dilute in 5% dextrose or 0.9% saline to a concentration of 6.6 mg/ml. Administer slowly over 1-2 hours per dose. Monitor renal function and urine output. Contraindications: Severe renal disease, anuria. Drug interactions: May chelate other metals, so avoid concurrent use of other chelators. 2) D-Penicillamine: Dose: 110 mg/kg/day PO, divided into 4 doses (q6h) for 1-2 weeks. Administer on an empty stomach 1 hour before meals. Contraindications: Penicillin allergy, renal insufficiency. Drug interactions: May increase the effects of immunosuppressants. 3) Succimer (DMSA): Dose: 10 mg/kg PO q8h for 10 days. May be used as an alternative to D-penicillamine. Contraindications: Hypersensitivity to succimer. Drug interactions: None significant. 4) Maropitant (Cerenia): Dose: 1 mg/kg SC q24h or 2 mg/kg PO q24h for vomiting. Contraindications: Hypersensitivity. Drug interactions: None significant. 5) Omeprazole: Dose: 0.7-1.5 mg/kg PO q24h for gastroprotection. Contraindications: Hypersensitivity. Drug interactions: May alter metabolism of other drugs. 6) Famotidine: Dose: 0.5-1 mg/kg IV or PO q12h. Contraindications: Hypersensitivity. Drug interactions: May reduce absorption of other drugs. 7) Furosemide: Dose: 1-2 mg/kg IV or IM q8h for oliguric renal failure. Contraindications: Anuria, hypovolemia. Drug interactions: May cause electrolyte imbalances. 8) Blood transfusion: Administer packed red blood cells or whole blood at a dose of 10-20 ml/kg IV, as needed. 9) Fluid therapy: Lactated Ringer's solution or 0.9% saline at a rate of 10-20 ml/kg/h initially, then adjusted based on hydration status and urine output. 10) Antioxidants: Vitamin E (10-20 IU/kg PO q24h) and S-adenosylmethionine (SAMe) (20 mg/kg PO q24h) may be used to support liver function. Always consult the latest edition of Plumb's for specific dosing and safety information.

Evidence-based literature on zinc toxicosis in veterinary medicine is limited but informative. A retrospective study by Gurnee et al. (2015) evaluated 20 dogs with zinc toxicosis and found that the most common clinical signs were vomiting, lethargy, and anemia. The study reported a mortality rate of 10%, with all deaths occurring in dogs with severe anemia and acute kidney injury. Another study by Richardson et al. (2012) described the successful use of CaNa2EDTA in 15 dogs with zinc toxicosis, with a mean recovery time of 5 days. A case series by Brown et al. (2018) highlighted the importance of early foreign body removal, as dogs that underwent endoscopic retrieval within 24 hours had a better prognosis. Consensus guidelines from the American Society for the Prevention of Cruelty to Animals (ASPCA) Animal Poison Control Center recommend chelation therapy with CaNa2EDTA or D-penicillamine for confirmed zinc toxicosis. The ACVIM (American College of Veterinary Internal Medicine) has not published specific consensus statements on zinc toxicosis, but general toxicology guidelines support the use of chelation therapy. A study by Smith et al. (2020) evaluated the use of succimer as an alternative chelator and found it to be effective with fewer side effects. Overall, the evidence supports prompt decontamination, foreign body removal, and chelation therapy as the mainstays of treatment. Prognosis is favorable with early intervention, but delayed treatment can lead to fatal complications. Further research is needed to establish optimal chelation protocols and long-term outcomes.